ReviewOncoTargets and therapy2022
Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments.
Anderley Gordon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this paperpooled ittrialcites it